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 A 21st century perspective on hypothalamic–vascular–pituitary unit function  
[Au: our journal style is to write 21st century in full as ‘twenty first’, which would take 
the title over the length limits for this type of article. We also use ‘perspective’ for a 
specific opinion-based article. To reduce the length of the title and avoid the use of 
perspective, I suggest the following title modification:  
“An updated view of hypothalamic–vascular–pituitary unit function”. OK?] 
[Au: you use a mixture of hypothalmo and hypothalamic in the main text. I suggested 
consistently using on hypothalamic, changes throughout main text also OK?] 
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Membrane Proteins and Receptors (COMPARE), University of Birmingham, Edgbaston, B15 
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Birmingham, B15 2TH, UK. [Au: please include the street name for all addresses] 
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Abstract [Au: edits OK?] 
The discovery of novel functional adaptations of the hypothalamus and anterior pituitary 
gland for physiological regulation has transformed our understanding their interaction. The 
activity of a small number of hypothalamic neurons can control complex hormonal signalling, 
which is disconnected from a simple stimulus and subsequent hormone secretion relationship 
but is dependent on physiological status. The interrelationship of hypothalamic neurons and 
pituitary cells with the vasculature has an important role in determining the pattern of 
neurohormone exposure. Cell in the pituitary gland form networks with distinct organizational 
motifs that are related to the duration and pattern of output. These networds are modified in 
different physiological states and can persist after cessation of demand, which results in 
enhanced function [Au: edit OK?]. Consequently, the hypothalamus and pituitary can no 
longer be considered as having a simple stratified relationship: they form a tripartite system 
with the vasculature, which must function in concert for appropriate hypothalamic regulation 
of physiological processes, in particular reproduction [Au: edit OK? I think it’s important 
to mention reproduction in the abstract here]. An improved understanding of the 
mechanisms underlying these regulatory features has implications for current and future 
therapies that correct defects in the hypothalamic–pituitary axis. In addition, recapitulating 
proper network organization will be an important challenge for regenerative stem cell 
treatment. 
[Au:For your information, H1 and H3 refer to the level of heading and will be removed 
before proofs are made. H1 subheadings can have max 38 characters inc spaces. H3 
subheads can be of any length. Subheads have been edited to fit these limits, where 
indicated] 
[Au: I think the Review would benefit from a figures introducing the basics of the 
concepts you discuss. I think this will be important to increase the impact of the 
paper, and for our less informed readers who are endocrinologists, but not particularly 
familiar with the neuroendocrine aspects. I have included the details of the figures you 
might wish to consider adding at the end of this document. I have also indicated in the 
main text where I think new figures might be useful additions. When you submit your 
revisions, please submit any new figures and I will work with our art editor to generate 
the first versions. We can revise these before making the final proof. If you wish to 
discuss these in greater detail before submitting, please do not hesitate to contact me] 
[H1] Introduction [Au: I have moved the second section (originally called 
‘Hypothalamic–pituitary axes’ of your original draft to here to serve as an introduction 
(the opening section is always titled ‘Introduction’ in our style guide). I think this text is 
more appropriate here and sets up the rest of the article nicely. Please also include the 
appropriate references in this section] 
To maximize reproductive success, via the appropriate timing of ovulation, lactation or body 
growth, the output of several hypothalamic–pituitary axes are dramatically altered  [Au: edit 
OK?]. These adaptive changes occur over differing time scales, with varying frequencies and 
levels of predictability [Au: is there a general review you can cite here?]. For example, the 
increase in growth hormone (GH) output at puberty is largely predictable [Au: meaning the 
levels are predictable or simply that it occurs?]. On a relatively short time scale [Au: 
meaning measured in days?], the surge in luteinizing hormone (LH) secretion required for 
oestrus is an acute change that occurs regularly once every reproductive cycle and, in humans, 
continues for years in the absence of pregnancy. On a longer time scale [Au: meaning 
months/years?], the increase in prolactin required for lactation is maintained for a variable 
time (which depends on when offspring are weaned) and recurs at each pregnancy, but is 
unpredictable before gestation [Au: edit OK to avoid repetition of ‘pregnancy’?]. These 
large changes in output require modification of both hypothalamic and pituitary function, but 
are reversed after pregnancy, which  likely reflects the fact that these processes need to be 
repeated in subsequent pregnancies [Au: edit OK is this what you?]. A mechanistic 
understanding of these alterations in hypothalamic–pituitary function is fundamental to 
interpret and treat defects that lead to endocrine diseases [Au: please be more specific here 
as to the diseases you mean in this context to set the scene for your review]. In this 
Review, we will focus on three pituitary axes that have roles in driving changes in 
physiology; the gonadatropin, prolactin and growth hormone axes [Au: addition OK?]. The 
level of our understanding varies for each of these axes and  the features that might serve as 
general principles will be highlighted in the text [Au: edit OK?].  
 
[H1] Beyond stimulus-secretion coupling [Au: I think you could include a simple figure 
in this section on stimulus-secretion as an addition to BOX 1.  And based on the 
summary figure you have already submitted. I think these concepts will work well in 
graphical form for our less informed readers] 
The speed of communication between the brain and peripheral tissues is highlighted by 
muscle contraction, which requires the transfer of electrical signals from axons via the 
neuromuscular junction [Au: edit OK? Is this what you mean here?]. This sequence of 
events, known as excitation-contraction coupling1, takes <1 s in mammals and is highly 
plastic [Au: please elaborate on what you mean by plastic in this instance]. Similarly, in 
the hypothalamus just a few thousand neurons can also send signals to the periphery, in this 
case toward the median eminence (ME) via a specialized neurohaemal junction [Au: edits 
OK?]. Here, nerve terminal depolarization, either originating from the perikarya2 or the 
terminal itself3, allows the sufficiently rapid entry of calcium ions to trigger exocytosis of 
neurohormones towards the first loop of the portal fenestrated capillaries [Au: please 
reference this statement here]. This rapid (< 1 s) sequence of events was termed ‘stimulus-
secretion coupling’ due to the clear similarities with excitation-contraction coupling4,5. Soon 
after release, neurohormones pervade the second loop of fenestrated capillaries within the 
downstream pituitary gland, before binding to cognate receptors on endocrine cells to induce 
pituitary hormone exocytosis through a second ‘stimulus-secretion coupling’ event6-9.  [Au: I 
think here might be a nice place to include a figure detailing these events for our less 
informed readers. A simple outline/schematic would be sufficient and that will set the 
scene for understanding the different axes later in the text] 
In the second half of the twentieth century (and building on Harris’ work on the 
hypothalamus–pituitary axis [Au: please reference this statement with a reference to 
Harris’ work for our less informed readers]) the analogy between excitation-contraction 
and stimulus-secretion coupling was developed further [Au: edit OK?]10. However, 
important and fundamental differences exist between the two processes. Specifically, in the 
hypothalamus, endogenous [Au: circadian] rhythms exist and the time scale for pituitary 
hormone release is much longer (measured in minutes to several hours) [Au: edit OK? 
Please reference this statement]. Nevertheless, the analogy with neural control of locomotor 
activity led to a generally accepted model of hypothalamic regulation of pituitary function. 
Specifically, the excitation of specific hypothalamic neuron populations, determined by 
higher brain centres and peripheral feedback, is relayed as an unmodified series of signals to 
drive balanced pituitary hormone output [Au: please reference this statement]. The release 
of neurohormones and subsequent transportation and the effects on target cells were 
previously considered to be passive events in the regulation of pituitary hormone secretion, 
with only variation in the number of endocrine cells seeming to affect response levels11,12. 
Similarly, the alterations in gene expression and cell proliferation, which support maintenance 
of hormone output, were simply considered a correlated response to hypothalamic regulation 
of secretion [Au: please reference this statement].  
In the early twentyfirst century, a series of paradigm shifts in our understanding of the 
hypothalamic–pituitary system was established as a consequence of newly developed tools 
and techniques [Au: such as?] for use in genetically modified mice [Au: please reference 
this statement with some examples]. The use of these methods have shown that both the 
pituitary gland and portal system can no longer be considered as static structures simply 
responding to neurohormonal regulation (BOX 1) [Au: edits OK to shorten sentence? I 
think the text box should be cited later in the text as more of a summary section]. In 
addition, hypothalamic neuron function has been found to be more dynamic than initially 
thought, which might, rather than changes in excitation, contribute to modifications in its 
regulation of the pituitary under different physiological states [Au: edit OK? Please 
reference this statement].  
 
 [H1] Gonadotroph axis 
The reproductive system is critically dependent upon pulsatile secretion of gonadotrophin-
releasing hormone (GnRH) and LH; however, the understanding of pulse generation has been 
hampered by the complexity of the regulatory mechanisms, many of which are lost in in vitro 
preparations [Au: please include the references here also as examples]. Investigators 
working in the late 1980s using pituitary portal bleeding and microdialysis documented the 
pulsatile nature of GnRH release into the portal vasculature of the sheep, monkey and rat25-31, 
and showed a strong correlation between GnRH and LH pulses28,32,33. However, the scattered 
distribution and relative paucity of GnRH cell bodies limited the investigation of the cellular 
events that lead to pulsatile secretion of LH in vivo. In the past few years, the development of 
optogenetic techniques in rats and mice and an ultra-sensitive ELISA capable of measuring 
LH levels in small whole blood samples34 has enables investigators to dissect the GnRH 
neuron excitation parameters that generate LH pulses35. In these studies, the stimulation of 
just 60 GnRH neurons can trigger short-lived increases in LH secretion that resemble 
endogenous pulses [Au: Edits OK? please reference this statement]. Given the critical 
importance of GnRH neurons to the survival of all mammalian species, a degree of functional 
redundancy within this cell population is expected. Indeed, activating ~5% of the GnRH 
hypophysiotropic neurons seems to be sufficient to generate an LH pulse [Au: please 
reference this statement]. This finding is consistent with studies in which just 10% of the 
GnRH neuron population is sufficient to maintain pulsatile LH secretion36,37. When the timing 
and frequency of stimulation is varied a brief (2 min) optogenetic stimulation at high 
frequency (10 Hz) evokes an LH pulse, whereas shorter periods and lower frequencies cannot 
elicit LH output that resembles endogenous pulses35. [Au: edit OK?] This finding was also 
the case for a bursting pattern of stimulation [Au: meaning of LH secretion? How is a 
bursting pattern defined in this context?], which had been assumed to be effective for pulse 
generation and the focus of many previous studies38 [Au: meaning that this mechanism was 
the only one thought to be necessary of LH output?]. Whether such a stimulatory signal 
exists in situ [Au: meaning within the organism?] and where its origin might be is 
unknown, although a ‘GnRH pulse driver’ might be located in the mediobasal–hypothalamus, 
specifically at the level of neurons co-expressing kisspeptin, neurokinin B, as well as 
dynorphin A (so-called ‘KNDy’ neurons)39,40. [Au: Edits OK? perhaps you can expand on 
that specific evidence here for clarify?] 
Pulsatile secretion of GnRH requires synchronization [Au: of the secretion and/or pulsatilty 
itself? What do you mean in this context?] within the GnRH neuron population. While the 
cell bodies of GnRH neurons are scattered throughout the basal forebrain, their projections 
have dendrodendritic bundling, that is they share synapses [Au: edit OK, is this what you 
mean?]41, and become highly concentrated around the ME [Au: please reference this 
statement]. Fascinatingly, these projections simultaneously receive and integrate synaptic 
inputs — they possess both axonal and dendritic characteristics, leading to their description as 
‘dendrons’, before finally acquiring an axonal morphology within the ME and ramifying into 
numerous terminals that appose blood vessels42. [Au: I think this could be represented in 
the Figure also. It will then also give context to the vasculature aspect of the article] 
Dendrons might be an ideal location for putative afferent axons to modulate the excitability of 
multiple GnRH neuron dendrites, and for multiple GnRH neurons to align their firing pattern, 
which thereby provides a potential mechanism for their synchronized activity directly in the 
mediobasal hypothalamus [Au: is this your opinion?]. An additional source of pulse 
synchronization is in the ME, where hypophysiotropic GnRH neurons terminate within the 
external zone close to endothelial cells of the portal vasculature43. Endothelial cells in the ME 
might modulate GnRH release through nitric oxide secretion (which has been reviewed 
elsewhere44) [Au: edit OK? I would include some of the original reference here also to 
reduce the nu,ber of other reviews cited]. At the ME, nitric oxide is spontaneously 
released from an endothelial source and follows a pulsatile and cyclic pattern of 
secretion45, and inhibition of nitric oxide synthesis [Au: by local do you mean specifically 
in the ME or a wider area?] can disrupt reproductive cyclicity46. Conversely, in the GnRH 
neuron perikarya, basal nitric oxide synthase activity might provide the tonic inhibition of the 
GnRH neural system required to maintain nadir levels of LH [Au: edit OK?] 47. [Au: this 
mechanism to be represented in the figure also?] 
Once released into the ME, the transport of GnRH to the pituitary, and the pattern of 
gonadotroph exposure to the neurohormone, have been largely assumed to represent a simple 
linear process [Au: please reference this statement]. However, the use of fluorescent 
tracking using 4 kDa dextran, which mimics the size of most hypothalamic neurohormones, 
has shown that the diffusion processes, both at the level of the ME and the pituitary 
capillaries, are complex and non-linear 7. [Au: edit OK?] Consequently, the portal vessel 
network might function as a ‘physical integrator’, enabling neurohormones to be transferred 
from the ME to the gonadotroph within a few seconds [Au: can you cite a reference here?]. 
Once in the blood stream, the moderately rapid clearance rate [Au: can you define this rate 
here?] of LH underlies [Au: meaning it generates it?] the specific asymmetric pulse shape 
of this hormone, which is characterized by a fast increase immediately followed by a slower 
decrease34. Importantly, a faithful delivery of the pulsatile pattern of GnRH secretion to the 
pituitary is crucial for gonadotroph function48 [Au: please include some of the original key 
references for this finding]. For example, high GnRH pulse frequencies (>1 pulse per h) 
activate LH production, whereas low frequencies (<1 pulse per 2–3 h) preferentially induce 
follicle-stimulating hormone (FSH) synthesis and release49. Overall, the intricate relationships 
between pulsatile GnRH release, secretory competency of the pituitary gonadotrophs and 
regulatory mechanisms within the vasculature, generate the rhythmic fluctuations in LH 
secretion.  
[H3] GnRH and LH surge generation 
The GnRH/LH surge mechanism is sex specific and normally occurs only in women 50-52 [Au: 
Please include the original references and only one Review here; it might be interesting 
to add a note about when it might occur in men]. During the oestrous cycle, increasing 
concentrations of plasma oestrogen alter feedback to the GnRH neuronal afferent networks 
and gonadotrophs from negative to positive to induce the gonadotrophin surge [Au: please 
reference this statement]. That the oestrogen-responsive kisspeptin neurons in the rostral 
periventricular area of the third ventricle have a critical role in enabling ovulation in rodents 
by activating GnRH neurons is now well accepted 53.  Importantly, the relative contribution of 
the hypothalamic and pituitary levels to the oestrogen-induced gonadotropin surge seems to 
be species-dependent, with the latter the predominant mechanism in human and non-human 
primates54. In the female sheep, the GnRH surge is composed of high-frequency pulsatile 
events superimposed on a constantly elevated level of GnRH release, although whether the surge is driven by a fundamentally altered pattern of GnRH secretion55, or by a simple increase in the frequency of pulsatile secretion is unclear [Au: edit OK?]56. This huge increase in GnRH 
secretion continues for a period of 24 h, considerably longer that the duration of the LH surge 
it induces, before returning to a strictly episodic pattern of release31,55,57. The firing pattern of 
GnRH neurons needed to generate the GnRH/LH surge is unknown. However, that the 
prolonged firing of an increased number of GnRH neurons is required for the secretion of 
surge levels, compared with that required for a pulse, is a reasonable assumption [Au: edit 
OK? Have I retained your meaning here?]. Indeed, mice with 10% of the normal GnRH 
neuronal content failed to ovulate [Au: meaning 90% were ablated? How so?], but cyclicity 
was restored when approximately 30% of the GnRH population was present 36,37.  [Au: please 
include a little more detail of how these studies were conducted] 
In addition to the putative change in GnRH population electrical activity, anatomical changes 
are found within the external zone of the ME where GnRH nerve terminals are ensheathed by 
tanycytes58,59. The cellular conformation changes with fluctuating oestrogen profiles 
throughout the oestrous cycle. For example. in rats, semaphorin-7a-dependent structural 
remodelling of tanycytes occurs during the preovulatory surge, resulting in release of the 
engulfed axons and direct access of GnRH nerve terminals to the portal vasculature [Au: 
please reference this statement also]. By contrast, fenestrated endothelial cells of the 
hypothalamic–hypophyseal portal vessels release semaphorin-3A, which is thought to induce 
GnRH neuron axonal growth and sprouting within the ME as a function of the oestrous 
cycle60. [Au: also data from rats?] These mechanisms are likely to enable the generation of 
high concentrations of GnRH, which evoke the GnRH/LH surge, to be released into the 
pituitary portal circulation61-63. 
Within the pituitary, the distinct network organization of gonadotrophs14 and their large scale 
reorganization during puberty15 suggests that homotypic cell organisation [Au: meaning the 
cells reorganize according to their type? Please expand on what you mean here. Can this 
be included in the figure?] might have a functional role [Au: in puberty itself?]. However, 
this reorganisation [Au: edit OK? Is this what you mean here?] has not been studied in 
detail in the other pituitary axes to date. Although the dynamic gonadotroph responses at the 
time of the proestrous surge have not yet been described in vivo, static snapshots [Au: 
meaning ‘individual readings’?] in rats and sheep suggest that changes occur in 
gonadotrophin subunit expression, granule distribution and GnRH receptor abundance64,65. 
[Au: edit OK?] However, mRNA sequencing of the anterior pituitary glands from women 
[Au: of what age?] reveal that genes regulating [Au: gonadatroph?] secretion, blood 
pressure and cell adhesion were all enriched during proestrus66. Likewise, immortalized cell 
lines and cells in pituitary slices both extend cellular processes and increase their cellular 
movement at [Au: stages that replicate puberty?] puberty15 and following GnRH 
stimulation67. These findings suggest that changes in the relationship of the gonadotroph 
network with the vasculature might modify the secretory response of gonadotrophs68,69. [Au: 
edit OK?] 
[H3] Clinical relevance 
The mechanisms that underlie both pulsatile secretion and surge generation of LH have 
important implications for the treatment of infertility in women [Au: edit OK?]. For example, 
polycystic ovarian syndrome (PCOS), the most common anovulatory cause of infertility70 and 
affects >100 million women worldwide, is associated with a dysregulation of the normal 
pattern of LH secretion [Au: please reference the latter part of this statement also]. 
Whether the origin of this multi-factorial disorder is at the level of the hypothalamic–pituitary 
axis is unknown71, but PCOS is characterized by increases in GnRH pulse frequency [Au: of 
how much? Can this be quantified?] and sensitivity of the pituitary gland to the 
neurohormone72,73. Consequently, potential interventions that modify the dynamics of GnRH 
output, its transport to the ME or its actions in the pituitary might have implications for the 
treatment of PCOS [Au: is this opinion?]. This is also the case for congenital 
hypogonadotropic hypogonadism  [Au: we avoid using two letter abbreviations where 
possible. HH removed OK?], which results from a pituitary or a hypothalamic defect with or 
without anosmia [Au: please reference this statement for clarity also]. Several novel gene 
mutations that are associated with this disorder have been identified, including those encoding 
neuropeptides [Au: such as?], transcription factors [Au: such as?] and G-protein coupled 
receptors[Au: such as?] [Au: please give examples here]74. To induce female fertility, 
hypogonadotropic hypogonadism of pituitary origin can be reversed by subcutaneous 
injections of FSH followed by human chorionic gonadotrophin or LH to trigger ovulation 
[Au: please reference this statement]. Conversely, hypogonadotropic hypogonadism of 
hypothalamic origin can be treated using GnRH pumps to restore pituitary hormone secretion 
[Au: please reference this statement]. Pulsatile GnRH has the advantage of decreasing the 
risk of multiple pregnancy and ovarian hyperstimulation syndrome75. In both situations, the 
pulsatility of GnRH or the rhythmic secretion of FSH and/or [Au: OK?] LH is required to 
obtain sufficient follicular maturation and proper ovulation76. Advances in understanding of 
GnRH secretion and its interactions with LH are essential for designing novel, and indeed 
modifying existing, therapies for hypogonadotropic hypogonadism. For example, some 
patients [Au: roughly how many? Is there a % you can include here?] with this disease, 
who are yet to undergo treatment, have transient phases of normal fertility77 [Au: edit OK?]. 
The underlying mechanisms and relevant therapeutic interventions to maintain this 
phenomenon might be elucidated by further investigation of pulsatility and rhythmicity [Au: 
edit OK?]. 
 
[H1] The prolactin axis 
The prolactin axis is unique amoung the pituitary hormonal systems, as in men and women 
who have not previously had sexual intercourse, it can be considered a system primed for 
activation by tonically inhibited by hypothalamic dopamine78 [Au: edit OK? Is this what 
you mean?]. [Au: ‘In this situation’?] Low concentrations [Au: can this be quantified?] of 
circulating prolactin are maintained by short-loop feedback, with prolactin receptor-mediated 
stimulation of dopamine neuron firing rate leading to an increase in catecholamine 
production79 and output2. The timescale of the secretory response for prolactin (~10–20 min) 
requires the coordination of multiple neurons [Au: please reference this statement]. 
Specifically, tuberoinfundibular dopamine neurons undergo long-term coordinated changes in 
firing rate, which correlate with episodic secretion [Au: of prolactin?] in mice2. [Au: please 
expand on this finding. How do you mean long-term and what are the changes in the 
firing rate? I think you need to include a little more explanation here] Gap junctions and 
local dendritic dopamine release have been proposed to mediate this activity80,81, and 
integration of single cell firing rates seems to be involved in the generation of longer DA [Au: 
DA meaning dopamine?] release output events (N. Romano and P. Mollard, unpublished 
data).  
Variations in prolactin output occur in virgin female rats as a surge at proestrus, which 
coincides with that of LH82. Prolactin also increases following vaginal stimulation of rodents 
[Au: meaning it is true in mice and rats? Or has this only been shown in rats?] as twice 
daily surges83. These surges are coordinated by signals from the suprachiasmatic nucleus83, 
most likely through the actions of vasoactive-intestinal peptide84. At the level of the pituitary, 
lactotrophs form a network of honeycomb motifs that allow the congregation of cells along 
the fine pituitary capillary network85. [Au: can this be represented in a figure summarising 
the Prolactin axis?] This organization supports low levels of cell-cell coordination16, with a 
small proportion [Au: how many? Can this be defined?] of cells acting as coordinating 
nodes by functionally connecting distant ensembles [Au: please reference this latter part of 
the statement]. In addition to synchronizing Ca2+ activity, cellular organization also mediates 
the coordination of gene transcription86,87, with gap junction signalling enabling local 
correlation of bursts of transcriptional activity that are otherwise randomly timed [Au: please 
reference this latter part of the statement]. This mechanism resembles quorum-sensing 
where apparently random systems display complex activity as long as the components (in this 
case the cells) can interact, and might contribute to hormone gene expression and cell 
proliferation87,88,89. [Au: edit OK?] How gap junctions might orchestrate this mechanism 
remains unknown; however, regenerative Ca2+ waves and Ca2+-regulation (e.g. through 
NFAT) could be one possibility90. [Au: I think you need to expand on this highlighted (in 
grey) statement — e.g. why specifically could it be a possibility — or remove it 
altogether if this is too speculative] 
[H3] Increased prolactin output during lactation 
The long-term requirement for large increases of circulating prolactin in lactation is 
associated with a decrease in dopamine output, which begins in late pregnancy91 and is 
coincident with a surge of pituitary prolactin secretion [Au: please reference this latter 
statement – 91 also? Edit OK to simplify sentence and avoid repetition?]. The dopamine 
tone needs to be strongly decreased throughout lactation to enable the necessary increase in 
circulating prolactin, and is mediated by a decrease in phosphorylation of tyrosine 
hydroxylase, the rate-limiting enzyme for dopamine synthesis91. This mechanism is not the 
result of a reduced feedback of prolactin on dopamine neurons, which remain electrically 
responsive at the level of the cell body,  but rather, neuronal firing becomes uncoupled from 
dopamine secretion2. [Au: edit OK? have I retained your meaning here?s] Remarkably, 
the reduction in dopamine tone is accompanied by the production of opioids92,93, which might 
enable these neurons to stimulate prolactin secretion [Au: is this latter statement an 
opinion?]. 
In concert with changes in the hypothalamic inhibition of prolactin secretion, substantial 
alterations occur in the pituitary to support the 10–50-fold increase in prolactin secretion that 
is required for milk production in mammals93 [Au: edit OK?]. In humans and rats, this [Au: 
milk production?]  is generally accompanied by proliferations of lactotrophs, with some 
evidence of hypertrophy [Au: of the lactrotrophs?], although these results [Au: meaning 
the hypertrophy results?] are based on 2D histological studies [Au: edit OK?]94. By 
contrast, in lineage tracing and FACS studies in mice, lactotrophs become hypertrophied 
during lactation and increase their volume threefold rather than simply increasing in number 
[Au: edit OK?]95. Other investigators have confirmed these findings, and also showed that 
the lactotroph network in situ becomes highly-connected during lactation, which is associated 
with the strength of the suckling stimulus16. [Au: edit OK?] This increase in structural 
connectivity leads to a substantial increase [Au: of how much?] in the proportion of the 
subpopulation of lactotrophs that function as coordinating nodes and orchestrate increased 
output of prolactin [Au: please reference this statement].  
[H3] Memory of prolactin demand after weaning [Au: edit OK?] 
At weaning [Au: edit OK? I think the term weaning is well-enough understood to omit 
an explanation], a rapid decrease in prolactin secretion occurs as a result of a return of 
dopamine inhibition96. In rodents97,98 and humans99 basal prolactin secretion is reduced below 
that of virgin animals, which might reflect an enhanced pituitary response to dopamine 
inhibition100. Strikingly, and despite this reduction in basal prolactin secretion, lactotrophs 
remain enlarged and well-connected [Au: with each other? Or generally within the 
network? Please clarify here] at both the structural and functional levels16, with an increased 
proportion of cells acting as nodes [Au: what is the proportion? What does it change from 
and to? What is the specific function of the nodes at this stage? Possibly to be included 
in a new figure on the prolactin axis], which persists for many months after lactation has 
ceased [Au: edit OK, is this what you mean? please reference this statement]. Such hard-
wiring or ‘memory’ of previous stimuli, which was previously thought to only exist for 
neurons and immune cells, leads to a lactotroph network behaviour [Au: what do you mean 
specifically by ‘lactotroph network behaviours’ in this instance?] during subsequent 
lactations [Au: meaning after subsequent births?], which drives even higher concentrations 
of prolactin16. This mechanism is independent of reproductive experience per se, since it can 
be prevented by reducing the suckling demand [Au: please reference this statement].  
[H3] Clinical relevance 
The dysregulation of the prolactin axis, owing to either pituitary adenomas101 or as an adverse 
effect of treatment with antipsychotic drugs102, leads to impaired fertility. 
Hyperprolactinaemia is the second most common cause of infertility in women after PCOS 
[Au: please reference this statement; how many individuals does hyperprolactinaemia 
affect?]. A clear understanding of the interactions that lead to altered dopamine output and 
the response of the pituitary might help to identify novel treatment strategies for this disease. 
For example, further understanding the regulation of prolactin release by dopamine might 
enable the reduction in the doses of commonly-used dopamine receptor agonists, as their 
safety in the treatment of prolactinomas has been questioned103. [Au: why so? Please include 
a little extra detail] In rodent studies, prolactin seems to affect multiple neuroendocrine axes 
[Au: such as? Please include the axes here for clarity] 77, and these warrant further study to 
determine the potential effects of its over-secretion in humans. For example, 
hyperprolactinaemia might lead to changes in GnRH neuron activity via interactions with the 
GPR54/kisspeptin pathway in mice104 and GnRH pulsatility has been reinstated in mice with 
physiological hyperprolactinaemia by administration of kisspeptin105. [Au: edit OK?] By 
contrast, in studies using sheep with a lower prolactin dose [Au: lower dose than what? And 
how much lower?], no effects on hypothalamic kisspeptin expression have been seen [Au: in 
response to this treatment/administration please clarify here? edit OK?]106. An improved 
understanding of these pathways could aid the development of treatments for women with 
hyperprolactinaemia that is resistant to dopamine agonists [Au: please provide a reference 
for this dopamine agonist-resistant hyperprolactinaemia].  
[H1] The GH axis [Au: suggest a new figure for this section including the organisation 
and plasticity of the GH axis] 
In humans and animals in which it can be measured [Au: such as?], pulsatile GH output is 
present from birth107,108,109. However, the output is markedly increased at puberty when 
sexually-dimorphic body growth occurs110. [Au: edit OK?] Since the discoveries of GH 
releasing hormone (GHRH) and somatostatin that control GH secretion from pituitary 
somatotrophs111-113,  a remarkable advancement our understanding of GH pulse generation 
during critical physiological windows has taken place [Au: edit OK?].  
[H3] Pulsatile GHRH output 
Using genetically-modified mouse models with GHRH neurons marked with green 
fluorescent protein114, several investigators have defined the mechanisms that underlie pulse 
generation using ex vivo slices of brain [Au: edit OK?]. Before puberty, GHRH neurons are 
excitable neuroendocrine neurons with complex synaptic inputs115. These early stages of 
hypothalamic development ensure appropriate regulation of the somatotroph axis, as in the 
Ames dwarf mice in which loss of GH leads to a compensatory increase in GHRH cell 
number116, [Au: edit OK?] and programming effects of steroids on GHRH cell number and 
gene expression117 [Au: please expand on this latter statement. What specifically do you 
mean by ‘programming’ and how does the cell number and gene expression change?]. 
Modification of these synaptic inputs and electrical properties over the first 6 postnatal weeks 
correlates with and likely drives, at least in part, increased pituitary GH output and sexual 
dimorphism118. In all these studies, the intrinsic hourly rhythms of GHRH neuronal activity 
predicted by simulation studies of in vivo GH pulsatility have not been indentified115,119. 
However, somatostatin can generate GHRH neuron pulsatile output by delaying oscillations 
of action potential firing via a recurring inhibition of inhibitory GABAergic interneurons (that 
is, inhibition of inhibition)119. [Au: edit OK? Have I retained your meaning here?] 
Consequently, somatostatin can both acutely inhibit the excitability of GHRH neurons and 
also promote their patterned output together with more sustained GHRH neuron stimulation in 
response to other stimuli in the brain (for example, acetylcholine118) and peripheral tissues 
(such as, ghrelin) 113.  [Au: edit OK?] [Au: can these processes be represented in the a 
figure on the GH axis? E.g. to highlight the plasticity of these neurons during puberty?] 
[H3] Modification of pituitary somatotroph output 
No full description of the in vivo dynamics of GHRH and somatostatin neurons and their 
regulation of pituitary somatotrophs exist [Au: edit OK?]. This event can be viewed as a 
three-step process: delivery of neurohormone to target cells; cellular secretory responses to 
regulation; and entry of pituitary hormone into the peripheral circulation [Au: please 
reference this statement. Or is this based on opinion?]. In vivo imaging of the mouse portal 
system and somatotroph network have provided insights into the first step in this process and 
the role of the vasculature in shaping the pattern of exposure of the pituitary to hypothalamic 
neuropeptides7. Delivery of neuropeptides such as GHRH to the somatotroph network, which 
extends throughout the pituitary gland, follows specific vascular/capillary routes and results in 
specific temporal patterned regulation rather than a homogenous ‘immersion’ [Au: by 
‘immersion’ meaning the whole pituitary exposure to the secretagogue?] of the pituitary 
parenchyma in secretagogue [Au: please reference this statement]. In addition, the initial 
stimulation by GHRH evokes a coordinated enhancement of oxygen to the stimulated 
somatotroph network via increased capillary blood flow, which provides fuel for energy-
depleting secretory responses [Au: please reference this statement]. Indeed, the GH [Au: 
neuronal?] network is spatially organized versus the vasculature [Au: Do you mean that the 
GH network is organized in the same spatial manner as the vasculature? Do you mean 
all of the vasculature in this instance? please reference this statement], which suggests an 
important role of local oxygen regulation on GH release and that this may also be the case for 
other pituitary axes [Au: is there any evidence to support this highlighted statement? If 
not I suggest you remove it]. The second step in pituitary regulation has been characterized 
using ex vivo data from acute pituitary slices where the somatotroph network organization is 
preserved, in which the homotypic network-mediated coordination of stimulation, triggering 
long-lasting GH secretion20. These studies have also shown that network organization is likely 
to have a major role in the increased GH output at puberty. In particular, the GH network 
undergoes large changes in the volume to surface ratio [Au: of what specifically?] that 
coincides with the onset of puberty, before gradually returning to normal pre-pubertal levels 
by [Au: postnatal?] day 100 in mice [Au: please reference this statement]. Such changes 
correlate with sexually dimorphic patterns of output13. [Au: please expand on this 
statement, what do you mean precisely here?] Sex steroid manipulation also leads to rapid 
and dramatic increases in cell motility that remodels the network organization120 [Au: please 
can you expand on the details of this finding here]. [Sentences rearranged to improve 
flow OK? Have I retained you meaning here?] These findings highlight the importance of 
somatotroph network organization and its plasticity in the generation of pituitary somatotroph 
output. The vasculature also has an important role in somatotroph output, where in vivo 
imaging shows that capture of secreted GH is a controlled event where the perivascular space 
acts as a gate-keeper for hormone entry into the capillary lumen120. The relationship between 
neuronal network organization and the vasculature in the pituitary is, therefore, central to the 
delivery of incoming hypothalamic signals, and the build-up of GH pulses within capillaries. 
[H3] Clinical relevance 
GH deficiency resulting from congenital defects or acquired following traumatic brain injury, 
pituitary tumours or cranial irradiation121,122, is commonly treated with a daily subcutaneous 
dose of recombinant GH in childhood to increase growth rate [Au: please reference this 
latter statement]. However, considerable uncertainty exists regarding the optimal dosage or 
regime, and current treatments [Au: specifically GH injections?] do not fully recapitulate the 
physiological pattern of GH secretion [Au: please reference this statement]. One potential 
therapy is repopulation of the pituitary with stem cells, which has been investigated in the 
mouse [Au: addition OK? was this approach successful?]123. However, such approaches 
would require the recapitulation of the normal cellular organization to achieve normal 
pulsatility and homeostatic regulation [Au: edit OK?].  
Patients with acromegaly, which results from a GH secreting pituitary adenoma, frequently 
have glycaemic disorders: a lack of GH pulsatility modifies lipolysis, whereas overall GH 
hypersecretion can induce insulin resistance124. Consequently, an improved understanding of 
the mechanisms that determine the pattern of GH output might help to define new therapeutic 
options for dyslipidaemia or diabetes mellitus. In addition, GH pulsatilty also has an 
important role in a subgroup of patients who have clinical acromegaly with increased insulin-
like growth factor 1  [Au: abbreviation used once removed OK?], but unaltered mean 24-h 
GH concentration compared with healthy controls125,126. Altered GH pulsatility might explain 
the clinical presentation of this sub-group of patients, and our new understanding of the 
mechanisms underlying patterning of pituitary output might explain the abnormal GH axis 
function in these individuals and warrants further investigation [Au: edit OK?].   
[H1] Conclusions  
The examples in this Review provide new insights into regulation of three hypothalamic–
pituitary axes and demonstrate that these mechanisms are not a simple relay of stimulus-
secretion coupled events [Au: edit OK?]. The disconnection or modulation of hypothalamic 
excitation and neurohormone release, and an active role of the vasculature and pituitary in the 
network-mediated modification of responses, demonstrates that this view of the 
hypothalamic–pituitary system is over-simplistic (FIG. 1). [Au: we avoid first citing figures 
in the conclusions, but I think the addition of new figures as suggested above we negate 
the need for this Figure here and these points can be introduced earlier. You can then 
refer back to the ealier figures here in the conclusions] [Au: sentence removed here to 
avoid repetition] Given that the hypothalamic arcuate nucleus contains no more than a few 
thousand parvocellular neurons, the rapid development of techniques for interrogating 
neuronal function should enable the characterization of this structure’s regulation and output. 
Such studies will be invaluable for the deeper understanding of mammalian physiology, as 
this region controls a much larger panel of known body functions than any other brain region. 
In the vasculature and pituitary gland, many of the mediators of functional modulation remain 
unknown. Although loss of Prop1, which is essential for pituitary hormonal cell development, 
leads to loss of organ vascularization127, studies of the processes leading to normal 
vascularization and its modification have not been reported to date. Similarly, hypothalamic 
and steroid factors have been shown to regulate cell network organization19,20,120 but the 
underlying mechanisms and mediating factors are yet to be identified. The alteration of the 
gonadotroph network in mice with a developmental block of corticotroph terminal 
differentiation14, suggests that the mechanisms will be complex and involve interaction 
between multiple pituitary cell types. [Au: I suggest moving this information (highlighted 
in grey) into the preceding sections where appropriate. We try to avoid including new 
information like this in the conclusions, which should be for summing up the key points. 
These findings might have more impact in the earlier sections]  
The regulation of pulsatile pituitary secretion must now be considered as an integration of 
hypothalamic, vasculature and pituitary regulation, which has further implications for the 
understanding of disease [Au: edit OK?]. For example, the identification of kisspeptin has 
provided an exciting new target for the treatment of infertility128. The uncoupling of neuronal 
excitation and hormone output also has deeper implications such as in the case of ageing [Au: 
addition OK? Is this what you mean here?]. For example, the reduction in GH output with 
age might be due to a failure of neurohormone secretion from GHRH neurons that are excited 
under normal conditions [Au: edit OK?]129. The human pituitary gland can be accessed by 
transphenoidal surgery, which makes this structure ideal target organ for regenerative therapy 
[Au: please reference this statement]. The pituitary neuronal networks and their relationship 
with the vasculature must be considered for such therapy and the microenvironment clearly 
has an important role in the regulation of the pituitary gland, which might also affect the 
development of tumours [Au: edit OK?] 130. Finally, as pituitary networks are sensitive to 
peripheral regulation and their modification can persist for extended periods, they are a 
potential target for endocrine disrupting chemicals (EDCs). Indeed, the identification of EDC 
[Au: bisphenol A?]-mediated changes in expression of ICAM5 [Au: which specifically?] in 
the pituitary131 has led us to speculate that some EDC effects might be mediated by changes in 
pituitary organization132. These possibilities require further investigation for the understanding 
of both the aetiology and treatment of diseases associated with pituitary hormones [Au: edits 
OK?].    
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Key points [Au: edits OK?] 
• The activity of hypothalamic neurons is modified by inputs leading to heterogeneous 
activity; a small proportion of the total population can drive pituitary hormone 
pulsatility 
• Neurohormone output can vary following neuron excitation according to physiological 
status, which might  also lead to declining neuroendocrine output with age  
• The release of hypothalamic factors into the blood is modified by alterations in the 
juxtaposition of nerve terminals with the vasculature and tanycytes in the median 
eminence 
• Cells in the pituitary gland form homotypic networks, the organization of these 
relationships with the vasculature are distinct for each endocrine axis, which modifies 
responses to regulatory factors and patterns of output in response to demand [Au: edit 
OK?] 
• Reorganisation of the pituitary network can store long-term memories of increased 
output and learn to increase function on repeated challenge  
• Understanding the importance of coordinated hypothalamic–vasculature–pituitary 
function provides new understanding of a range of endocrine axes defects and targets 
for novel therapies  
 
[Au: a list of suggested Figures and content:  
Figure 1 – General introduction of the relationship between the 3rd ventricle, median 
eminence, portal vessels, vasculature and pituitary. We have a range of in-house options 
that can be adapted for this purpose. – I can send you an example or two if you wish 
Figure 2 – The gondadotroph axis – to include the organisation of the GnRH/LH network 
in the hypothalamic/pituitary/vasculature and with factors that might influence (e.g. NO). 
Might also include the homotypic organisation at puberty. E.g. a ‘before’ and ‘after’ panel 
Figure 3 – The prolactin axis – could include a representation of the lactotrophs and their 
development into networks – e.g. an expansion of what is represented in the bottom left of 
current Figure 1. 
Figure 4 – The GH axis – to include a graphical view of this axis and could include how 
this axis is modified to develop the pulsatility or the modification of pituitary somatotroph 
output 
If simpler, perhaps proposed Figures 2, 3 and 4 could be combined into a single, multi-
panel figure if you wish? 
Figure 5 – summary of our current understanding – based on your submitted figure 1, 
although some of these elements can be included in the above figure 
 
Figure 1 | Regulation of the hypothalamic-pituitary axes. In the past decade, a more complex relationship between the hypothalamus and pituitary than previously appreciated has emerged. a) At the level of the parvocellular neurons, complex inputs modify the excitation of neurons, which can vary coupling with neurohormone output at terminals of the median eminence (ME) through modification of intracellular pathways. 
b) Alterations in tanycyte ensheathment and the anatomical location of neuron terminals modify their interactions with the vasculature, changing the dynamics of neurohormone release. c) In the pituitary gland, changes in blood flow in the portal circulation alter the pattern of exposure of pituitary cells to neurohormone and nutrient supply to facilitate secretion. d) Cells of the pituitary gland are organised into intermingled networks with distinct morphological features, which can be altered to meet physiological demand, and relationships with the vasculature. 
  
[Au: I have made a number of edits to the text in this box to adhere to journal style 
and the overall flow of the article. However, I think some of these concepts could be 
represented in the suggested figures] Box 1 | Organization of pituitary cells into homotypic networks  During the past decade, we and others have shown that the pituitary somatotroph13, corticotroph14, gonadotroph14,15 and lactotroph16 lineages form 3D organized cell networks (reviewed in17,18) with the following features: 
• The lineages have distinct developmental programmes  
o Placement of each endocrine cell network occurs at distinct stages of pituitary organogenesis, before expansion in early post-natal life [Au: please include the 
references here].  
• The networks have distinct motifs that might relate to function.  
o For example, the organization of somatotrophs as clusters linked with strands13, while lactotrophs form a honeycomb structure16. [Au: how do these relate to 
function specifically? Or is this just an association?] 
• Hypothalamic factors generate network motifs  
o For example, the loss of growth hormone-releasing hormone (GHRH) itself leads to isolated somatotrophs, whereas somatotroph ablation with intact GHRH stimulation results in clusters of cells that are isolated from each other19.  
• The pituitary networks have functional relevance.  
o Critical roles have been described for pituitary networks in the integration, amplification and propagation of the neurohaemal hypothalamic signals that arrive via the median eminence. For example, the male somatotroph network responds to GHRH input with large, coordinated and oscillatory Ca2+ rises that outlast stimulus to drive large excursions in hormone secretion20.  
• Endocrine and non-endocrine cells interact to form homotypic networks [Au: edit OK? Is 
this what you mean here?].  
o For example, gap-junctions mediate coupling [Au: of what cells specifically?] with folliculostellate cells16,21, paracrine and autocrine interactions17,22 as well as the relationship between networks and the vasculature7,23,24. These interactions might help to alter [Au: somatotroph or simply hormone?] output. The distinct network motifs of lactotrophs are aligned with the fine pituitary capillary network, while somatotrophs form strands and clusters along the same vessels17. Similarly, gonadotrophs are in close approximation to one or more blood vessels via their protrusions15, whereas the corticotroph network has a looser arrangement 14. [Au: meaning these differences will shape how the 
neurohormones are released e.g. in terms of timing?]   
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